USO Oncology Network- Rocky Mountain Cancer Centers is a clinical research site located in Denver, Colorado, United States 80218-1237.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
USO Oncology Network- Rocky Mountain Cancer Centers has participated in 1 clinical trials.
Therapeutic areas: Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.
Sponsors: TransThera Sciences (Nanjing), Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
USO Oncology Network- Rocky Mountain Cancer Centers has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
USO Oncology Network- Rocky Mountain Cancer Centers has 1 clinical trials on record. Their work covers Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation.
USO Oncology Network- Rocky Mountain Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.